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Fluorescent squaramides as anion receptors
and transmembrane anion transporters†
Xiaoping Bao, ab Xin Wu, c Stuart N. Berry, acd Ethan N. W. Howe, c
Young-Tae Chang ef and Philip A. Gale *c
A series of squaramide-based anion transporters functionalised
with the 1,8-naphthalimide fluorophore has been developed for
improved ionophoric activity and fluorescent imaging in cells.
The transport of chloride ions across cell membranes is an
important physiological process, which regulates intra- and
extracellular pH, membrane potential, and cellular volume that
are crucial to many biological processes including cell migra-
tion, proliferation and diﬀerentiation.1 Intracellular chloride
concentrations are regulated by naturally occurring anion
channels in biological systems. A number of diseases, includ-
ing cystic fibrosis (CF), involve malfunctioning ion channels
(these diseases are collectively known as channelopathies).2
Development of small molecule synthetic anion transporters
(anionophores)3 capable of restoring chloride permeability
across lipid bilayers has been proposed as a new approach to
treating this class of disease.4 In addition, anionophores have
been reported to alter pH and ionic gradients between intra-
cellular compartments, which may lead to cytotoxicity, aﬀord-
ing the possibility of using these systems as anticancer agents.5
Our group have previously reported fluorescent anion trans-
porters based on naphthalimide-(thio)urea conjugates and
demonstrated their potential in studying the partitioning,
localisation and action of these fluorescent anionophores
within living cells using fluorescence imaging techniques.6
Those compounds, however, show modest anion transport
eﬃcacy compared with our most active transporters.7 To
improve the anion transport rate potentially allowing the use
of fluorescent transporters at lower doses, we decided to use
squaramide instead of (thio)urea as the anion binding site and
functionalise it with a 1,8-naphthalimide fluorophore.8 Com-
pared with the most extensively-utilised urea and thiourea
groups for anion complexation, the squaramide group confers
the advantage of enhanced anion-binding aﬃnities9 which has
been shown to benefit anion transport eﬃcacy in artificial
liposomes and cells.10 Herein we report the synthesis of four
novel fluorescent squaramide-based anion transporters 1–4
(Fig. 1) and study of their anion binding and transmembrane
transport properties as well as their live-cell imaging capabilities.
Compounds 1–4 were readily obtained by reaction of
4-(4-aminobutylamino)-1,8-naphthalimide with squarate mono-
esters (see ESI† for synthetic details and characterisation data).
Single crystals of compound 4 suitable for X-ray diffraction
analysis were obtained by slow evaporation of a DMSO solution
of 4 at room temperature. The crystal structure (Fig. 2) showed
Fig. 1 Structures of compounds 1–4.
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that compound 4 formed a 1 : 1 complex with DMSO via
two squaramide NH  O hydrogen bonds (N  O distances of
2.834(2) and 2.821(3) Å and N–H  O bond angles of 163.31 and
155.11, respectively). The 4-amino NH group of the naphthalimide
moiety was not involved in the hydrogen bonding interaction with
the DMSO solvate, despite the presence of a flexible 1,4-butylene
linker between the naphthalimide and squaramide moieties.
The binding aﬃnities of compounds 1–4 for chloride (as the
tetra-n-butylammonium salt) were evaluated via 1H NMR titra-
tions in DMSO-d6 (ESI†). For compound 1 upon the addition of
Cl, significant downfield shifts were observed for the two
squaramide NHs (Dd 4 +1.3 ppm) as well as two aromatic
CH protons from the 3,5-bisCF3-Ph group (Dd = +0.22 ppm). In
contrast, the naphthalimide 4-NH only underwent a very slight
downfield shift (Dd = +0.05 ppm) over the course of the titration
process, suggesting weak or no interaction of this proton with
chloride. A global fitting analysis assuming a 1 : 1 binding
model was employed to provide the binding constant (Ka), by
simultaneous fitting of the chemical shift changes of two
squaramide NHs as a function of added chloride.11 As shown
in Table 1, all compounds bound Cl with affinities ranging
from 160–520 M1. The relative strength of anion binding
(1 4 3 4 2 4 4) correlated with the Hammett constants (sp)
of their substituents. Much weaker binding was observed for
NO3
 (Ka o 10 M1) and stronger binding for the more basic
anion H2PO4
 (4400 M1 determined for 4, and higher affinity
of 4104 M1 was found for more acidic compounds 1–3).
Different from Cl binding, the complexation of tetrahedral
H2PO4
 by compound 4 seems to involve the naphthalimide
4-NH (Dd = +1.24 ppm) in addition to two squaramide NHs.
The chloride–nitrate transport activities of compounds 1–4
across lipid bilayers were evaluated using liposome-based
techniques based on a chloride ion-selective electrode (ISE,
Fig. 3).12 Briefly, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) unilamellar vesicles (mean diameter 200 nm) were loaded
with NaCl (489 mM, buffered to pH 7.2 with 5 mM sodium
phosphate), and then suspended in a NaNO3 solution (489 mM,
buffered to pH 7.2 with 5 mM sodium phosphate). The Cl/NO3

transport process was initiated by the addition of DMSO solution
of compounds 1–4 to these vesicles, and the resultant chloride
efflux was monitored using an ISE. Hill analysis13 was conducted
by following chloride efflux at different concentrations of trans-
porters (in mol% with respect to lipid concentration) to obtain
EC50 value (the concentration of transporter needed to achieve
50% chloride efflux in 270 s) and Hill coefficient n (indicating the
stoichiometry of the formed complex during the transmembrane
transport process14). As shown in Table 2, compound 1 with two
CF3 substituents possessed the best transport activity with a
substantially lower EC50 value (0.15 mol%) than previously
reported naphthalimide-(thio)ureas (40.4 mol%).6 The anion
transport activity of the compounds (1 4 3 4 2 4 4) followed
the same trend as their anion binding affinities. The Hill coeffi-
cient values ofB1 is consistent with a mobile carrier mechanism
via formation of a 1 : 1 receptor–anion complex (Fig. 4).
Fig. 2 Crystal structure of 4DMSO complex (CCDC 1530149).†
Table 1 Binding constants (M1) for the binding of compounds 1–4 to
Cl, NO3
 and H2PO4
 (tetrabutylammonium salts used for titrations) in
DMSO-d6 at 298 K as well as the corresponding Hammett constants (sp) of
the substituents
Compound Ka
a (Cl) Ka
b (NO3
) Ka (H2PO4
) sp
1 520 o10 4104c 0.85e
2 240 o10 4104c 0.54 f
3 290 o10 4104c 0.78 f
4 160 o10 4400d 0.00 f
a The values of binding constant (Ka) were calculated by fitting the
chemical shift changes of two squaramide NH resonances upon addi-
tion of TBACl assuming a 1 : 1 global fitting binding model. b All the
proton signals were found to undergo negligible change in their
chemical shifts during the titration process. c The binding constants
were estimated based on the chemical shift changes of aromatic CH
protons (adjacent to squaramide NH), due to the disappearance of NH
signals during the titration process. d This value was determined by
simultaneously fitting the chemical shift changes of two squaramide
NHs and the naphthalimide 4-NH resonances upon addition of TBACl,
using a 1 : 1 global fitting binding model. e The s value for 3,5-bisCF3-Ph
substitution was obtained from the pKa of 3,5-bis(trifluoromethyl)benzoic
acid ( J. Org. Chem., 2016, 81, 12116–12127). f Values obtained from ref.
Chem. Rev., 1991, 91, 165–195.
Fig. 3 Schematic illustration of the assays utilised for measuring the Cl/NO3
 antiport using the ISE (a); the H+/Cl symport or OH/Cl antiport using
the NMDG-Cl assay in the absence (b) and presence (c) of Gramicidin D (proton channel).
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Previous studies have shown that anion transporters could
dissipate the pH gradient across lipid bilayer in vesicle-
based experiments, via H+/Cl symport or OH/Cl antiport
mechanism.15 In order to explore this possibility, a series of assays
were performed using fluorescent dye HPTS (8-hydroxypyrene-
1,3,6-trisulfonic acid) as pH indicator and N-methyl-D-glucamine
(NMDG) chloride as a chloride ion source.16 Briefly, POPC lipo-
somes were firstly prepared containing 1 mM HPTS and 100 mM
NMDG-Cl buﬀered to pH 7.0, and suspended in an external
solution of 100 mM NMDG-Cl buﬀered to pH 7.0. Then, NMDG
(5 mM) was added as a base pulse to create a transmembrane pH
gradient (DpH = 1.0) and then the transporter was immediately
added into the above suspension to trigger ion transport process
and the resultant dissipation of pH gradient (Fig. 3b). As shown in
Fig. 5, the H+/Cl cotransport (or OH/Cl antiport) took place.
To quantitatively evaluate the Cl–H+/OH transport activity
of compounds 1–4, Hill analysis was also carried out to give
the corresponding values of EC50 and Hill coefficient (n).
From Table 2, the H+/Cl cotransport (or OH/Cl antiport)
activity of 1–4 followed the same order as that of the Cl/NO3

exchange. The presence of proton channel gramicidin D did not
affect the rate of pH gradient dissipation of all compounds
(ESI†), suggesting that H+ or OH transport is not rate-limiting
in this assay (acceleration of H+ transport by gramicidin D did
not improve the overall transport rate).16 Note that for all
compounds the EC50 values in the ISE Cl
/NO3
 exchange
assay is about 10 times the values in the HPTS assay, which
is consistent with the fact that the ISE assay requires a higher
ion flux (B500 mM of Cl and NO3
) than the HPTS assay
(5 mM of Cl and H+ or OH) for the transport process to reach
thermodynamic equilibrium.17
The presence of the 1,8-naphthalimide fluorophore within
compounds 1–4 allows them to be used for live cell imaging.
This was explored using the human lung carcinoma A549 cell
line. Fluorescence micrographs were collected after incubation
of the cells with compounds 1–4 (1.0 mM) for 24 hours and then
free compound was washed away with PBS buffer. Interestingly,
the most active transporter 1 exhibited bright green fluorescence
within the cytoplasm of A549 cells (Fig. 6), confirming its ability
to fluorescently stain the cells. Importantly, compound 1 up to
100 mM exhibited no toxicity to A549 cells as determined using a
CCK-8 assay (ESI†). In comparison, compound 2 showed a poor
fluorescent staining of A549 cells even at 10 mM. The second most
active transporter 3 demonstrated a marginal fluorescence in
A549 cells, which became stronger with increasing concentration;
however, a deliverability issue at 10 mM impeded its ability to stain
cells at high concentrations, under which conditions precipitation
was observed. The least active transporter 4 did not show any
detectable cell staining at all concentrations (ESI†).
In summary, a series of squaramide-based fluorescent anion
receptors were synthesized, bearing a 1,8-naphthalimide moiety
Table 2 Summary of anion transport parameters (kini, EC50 and n) and
calculated lipophilicity values (c logP) for compounds 1–4
Comp. kini
a
EC50,270s
b
(Cl/NO3
) nc
EC50,200s
d
(Cl–H+/OH) nc c log Pe
1 1.2 0.15 0.9 0.018 1.5 5.8
2 0.57 0.63 0.8 0.055 1.3 5.4
3 1.0 0.26 1.0 0.041 1.4 4.9
4 0.33 2.07 0.9 0.27 1.8 5.1
a Values determined by fitting the plot of relative chloride release ( y)
versus time (x) for 2 mol% transporter to lipid to an asymptotic function
y = a  b  cx. The initial rate of chloride release (kini in % s1) was
obtained byb ln (c). b Molar percentage with respect to lipid needed to
obtain 50% chloride eﬄux at 270 s from the Cl/NO3
 exchange assay.
c Hill coeﬃcient from Hill analysis. d Molar percentage with respect to
lipid needed to obtain 50% chloride eﬄux at 200 s from the HPTS assay.
e The logP values were calculated via VCCLab.
Fig. 4 Chloride eﬄux promoted by compounds 1–4 (2 mol% compound
to lipid) from unilamellar POPC vesicles containing 489 mM NaCl buffered
to pH 7.2 with 5 mM phosphate salts, suspended in 489 mM NaNO3
buffered to pH 7.2 with 5 mM phosphate salts. At the endpoint of each
experiment (300 s), the detergent (Triton X-100) was added to lyse the
vesicles and calibrate the electrode to 100% chloride efflux. Each point
represents the average of three trials. Pure DMSO was utilised as a control.
Fig. 5 H+/Cl symport or OH/Cl antiport facilitated by compounds
1–4 (0.2 mol% compound to lipid) from unilamellar POPC vesicles con-
taining both 1 mM HPTS and 100 mM NMDG-Cl buffered to pH 7.0 with
10 mM HEPES buffer and suspended in an external solution of 100 mM
NMDG-Cl buffered to pH 7.0 with 10 mM HEPES buffer. At the endpoint of
each experiment (200 s), the detergent was added to lyse the vesicles and
collapse the pH gradient for calibration of HPTS fluorescence. Pure DMSO
was utilised as a control experiment.
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as the fluorophore. Their anion binding and transmembrane
transport properties towards biologically important chloride
ions were investigated. The results indicated that these com-
pounds have moderate to relatively strong aﬃnities towards
Cl in DMSO-d6, with the highest aﬃnity of 520 M
1 observed
for the most acidic compound 1. Compounds 1–4 facilitate
chloride transport into the vesicles via Cl/NO3
 antiport and
Cl/H+ symport (or functionally equivalent Cl/OH antiport)
mechanisms. The relative transmembrane transport activities
of these compounds were mainly dictated by their chloride
affinities. The most active transporter 1 was found to have the
highest efficiency in fluorescent staining of living A549 cells
among the squaramides while being nontoxic and possessing
substantially higher anion transport activity than previously
reported fluorescent anion transporters.6 These results repre-
sent an important step forward in developing highly active
fluorescent transmembrane anion transporters that are useful
for studying the sub-cellular localisation and pharmacokinetics
of anion transporters in biological systems.
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